Home | MyCME | All CME | Blog | Psychlopedia

Top 10 CME Activities in the Past Week

  1. Diagnosing and Treating Patients With Mixed Features

    Rakesh Jain (Chair) et al

    Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they review the current diagnostic criteria for depressive episodes with mixed features, the risk of developing bipolar disorder in patients with this diagnosis, and recent treatment guidelines.

  2. Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

    Roger S. McIntyre

    You know that measuring cognition in your patients with depression is important. But cognitive assessment instruments can be difficult to access, expensive, time consuming, and not available in an electronic format. Read this CME activity to learn about a new free tool.

  3. Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

    Larry Culpepper (Chair), et al

    Is cognitive impairment keeping your patients with MDD from achieving full functional recovery? In this Academic Highlights, leading experts in MDD discuss the burden associated with cognitive impairment, effective strategies for assessing cognitive function, and available pharmacologic and nonpharmacologic treatment options.

  4. Comparing Treatments for Tardive Dyskinesia

    Leslie L. Citrome

    Many treatment interventions for tardive dyskinesia have been studied, but some have better evidence than others. Read this CME activity to get an expert's perspectives on the evidence for older and newer treatments so that you can minimize abnormal movements in your patients.

  5. Epidemiology and Prevention of Tardive Dyskinesia

    Christoph U. Correll

    What risk factors suggest that patients are more likely to develop tardive dyskinesia (TD)? Can TD symptoms be prevented? Read this CME activity to learn about the prevalence, epidemiology, and prevention of these abnormal movements from an expert.

  6. Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

    Larry Culpepper

    Pronounced deficits in executive function are found in up to one-third of patients with MDD, and this impairment can keep patients from achieving full functional recovery. In this CME activity, review the evidence regarding the effectiveness of available interventions to improve cognitive dysfunction in patients with MDD. "

  7. Impact of Cognitive Impairment on Functioning in Patients With Depression

    Raymond W. Lam

    For patients with depression, a return to normal functioning is a key treatment goal. Yet many of these patients demonstrate cognitive impairment even after they reach remission. In this CME activity, learn more about the association between cognitive dysfunction and work functioning, and find information on rating scales that measure functioning.

  8. Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

    Ruth M. Benca and Daniel J. Buysse

    Insomnia is often considered a symptom of psychiatric disorders when it actually needs to be addressed as a separate disorder. Read this CME Academic Highlights in which experts discuss ways to evalute patients with insomnia and to safely and effectively implement behavioral and pharmacologic treatments.

  9. Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

    Roger S. McIntyre

    How many of your patients achieve remission from depression with their first treatment? In this CME Health Spectrum activity, enter a virtual office to follow 2 patient cases about inadequate response to treatment. Learn as an expert describes strategies based on recent evidence-based guidelines.

  10. Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

    Diana O. Perkins

    Do you consider long-acting injectable (LAI) antipsychotics when selecting among treatments for schizophrenia? Take part in this CME activity to review the evidence for LAIs vs oral medications and to learn which patients may benefit most from this treatment option. Plus, discover the pharmacokinetic properties of LAIs and barriers to their use.